FOXO3 and cancer: proved that miR-124-3p.1 targeted AKT2 and SIRT1 to regulate the phosphorylation and deacetylation of FOXO3a, sensitizing hepatocellular carcinoma cells to sorafenib-induced apoptosis while increasing FOXO3a activity in cancer therapy (37).